Loading...
XNAS
UPC
Market cap3mUSD
Aug 28, Last price  
4.90USD
Name

Universe Pharmaceuticals Inc

Chart & performance

D1W1MN
XNAS:UPC chart
P/E
P/S
0.17
EPS
Div yield, %
Shrs. gr., 5y
-9.82%
Rev. gr., 5y
-10.27%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
IPO date
Mar 23, 2021
Employees
224
Domiciled in
CN
Incorporated in
KY

Valuation

No data to show